Peanut Allergy Treatment Market Trends And Growth Drivers Point To Strong Future Potential
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Peanut Allergy Treatment Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The market for peanut allergy treatments has seen significant expansion in recent years, with projections indicating an increase from $0.5 billion in 2025 to $0.55 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.8%. This historical growth can be explained by several factors, including a higher incidence of peanut allergies among children, the limited success of management strategies that rely solely on avoidance, a growing number of diagnosed food allergies, a heavy dependence on epinephrine for emergency care, and heightened awareness among medical professionals.
The market for peanut allergy treatments is projected to experience robust expansion over the coming years. By 2030, its value is anticipated to reach $0.8 billion, driven by a compound annual growth rate (CAGR) of 9.7%. This anticipated growth during the forecast period is fueled by progress in immunotherapy techniques, a higher number of approved disease-modifying therapies, increasing consumer interest in preventive allergy care, the development of biologics that target allergic pathways, and greater financial support for food allergy studies. Key developments shaping this period include the increased application of oral immunotherapy to achieve peanut desensitization, the expanding utilization of epicutaneous immunotherapy patches, the growing incorporation of biologic agents into allergy treatment protocols, the development of more pediatric-focused therapies for peanut allergies, and a heightened focus on sustainable, long-term methods for managing allergies.
Download A Free Sample Report For Comprehensive Market Insights:
Peanut Allergy Treatment Market Industry Drivers: What Is Driving Revenue Growth?
The growth of the peanut allergy treatment market is anticipated to be driven by investments in research and development for allergy therapies. Research and development (R&D) investment involves financial resources channeled by companies, organizations, or governments into activities focused on innovation, product advancement, and technological progress. Such investment in allergy treatment R&D plays a vital role in progressing peanut allergy therapies. It enables the development of novel immunotherapies and desensitization methods designed to minimize allergic responses and enhance the quality of life for individuals with peanut allergies. For example, in January 2024, the Victorian Government committed a strategic $12 million to Aravax, an Australian clinical-stage biotechnology company, to boost global peanut allergy treatment efforts. This funding was part of a larger $66 million round intended to advance Aravax’s innovative immunotherapy, PVX108. The initiative has received Phase 2 trial approvals from both the U.S. Food and Drug Administration (FDA) and Australia’s Therapeutic Goods Administration (TGA), highlighting its potential worldwide public health impact. Consequently, increased R&D investment in allergy treatments is propelling the expansion of the peanut allergy treatment market.
Peanut Allergy Treatment Market Segment Landscape And Growth Potential
The peanut allergy treatment market covered in this report is segmented –
1) By Drug Class: Antihistamines, Immunotherapies, Epinephrine, Other Drug Classes
2) By Route Of Administration: Injectable, Oral, Other Routes Of Administration
3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Other Distribution Channels
Subsegments:
1) By Antihistamines: Oral Antihistamines, Topical Antihistamines
2) By Immunotherapies: Oral Immunotherapy (OIT), Sublingual Immunotherapy (SLIT), Epicutaneous Immunotherapy (EPIT)
3) By Epinephrine: Epinephrine Auto-Injectors, Epinephrine Inhalers
4) By Other Drug Classes: Leukotriene Receptor Antagonists, Monoclonal Antibodies, Corticosteroids
Peanut Allergy Treatment Market Growth Trends: What Is Influencing The Future Outlook?
Key players in the market for treating peanut allergies are concentrating their efforts on the development of biologic therapies—specifically anti-IgE monoclonal antibodies—with the goal of delivering more precise and effective approaches to managing peanut allergies, ultimately enhancing patient outcomes and overall quality of life. These monoclonal antibodies are therapeutic agents engineered to bind to and neutralize immunoglobulin E (IgE) antibodies within the body. A notable example occurred in February 2024, when Novartis Pharmaceuticals Corporation, headquartered in Switzerland, received FDA approval for Xolair (omalizumab). This drug is designed to lessen allergic reactions, including anaphylaxis, in individuals aged one year and older who suffer from IgE-mediated food allergies. The approval was supported by findings from the NIH-sponsored Phase III OUtMATCH study, which demonstrated that patients treated with Xolair achieved significantly greater tolerance to food allergens compared to those given a placebo.
Peanut Allergy Treatment Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the peanut allergy treatment market are Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Limited, Viatris Inc., Regeneron Pharmaceuticals Inc., Hikma Pharmaceuticals plc, ALK-Abelló A/S, Amneal Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc, Stallergenes Greer plc, kaleo Inc., Aquestive Therapeutics Inc., Vedanta Biosciences Inc., Aimmune Therapeutics Inc., AnaptysBio Inc., Alladapt Immunotherapeutics Inc., Aravax Pty Ltd, Intrommune Therapeutics Inc., IgGenix Inc., DBV Technologies SA, Camallergy Ltd., HAL Allergy Group, Prota Therapeutics Pty Ltd.
Access The Complete Peanut Allergy Treatment Market Report:
Peanut Allergy Treatment Market Largest Region By Revenue And Market Share
North America was the largest region in the peanut allergy treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peanut allergy treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
